Silymarin Targets β-Catenin Signaling in Blocking Migration/Invasion of Human Melanoma Cells
2011
Silymarin Inhibits Melanoma Cell Migration
publication
Evidence: moderate
Author Information
Author(s): Mudit Vaid, Ram Prasad, Qian Sun, Santosh K. Katiyar
Primary Institution: University of Alabama at Birmingham
Hypothesis
Does silymarin inhibit the migration of melanoma cells by targeting the β-catenin signaling pathway?
Conclusion
Silymarin inhibits the migration of melanoma cells by inactivating the β-catenin signaling pathway.
Supporting Evidence
- Silymarin treatment reduced the migration capacity of melanoma cells in a dose-dependent manner.
- Treatment with silymarin resulted in decreased nuclear accumulation of β-catenin.
- Silymarin enhanced the phosphorylation of β-catenin at critical residues, promoting its degradation.
Takeaway
Silymarin, a plant extract, helps stop melanoma cells from moving around, which could help in treating skin cancer.
Methodology
The study used in vitro assays to assess the effects of silymarin on melanoma cell migration and invasion.
Limitations
The study primarily focused on in vitro models, which may not fully represent in vivo conditions.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website